Norway· NO-ID_2BB34A69-399D-4F7F-AFEE-A82AA911C414
Ridaura
A auranofin product containing auranofin, registered in Norway by Xediton Pharmaceuticals Inc. The same ATC class is registered in 5 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Auranofin is registered in 5 of 19 countries.
Countries holding a registration under ATC M01CB03 (auranofin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Auranofin · ATC M01CB03
5 / 19 countries
- Canada
- Finlandprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Auranofin
- Manufacturer
- Xediton Pharmaceuticals Inc
- Country
- Norway (NO)
- ATC code
- M01CB03
- ATC class
- Auranofin
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- gtin835659001012
- no_merkevare_idID_2BB34A69-399D-4F7F-AFEE-A82AA911C414
- no_varenummer21423560
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
113 interactions on record for auranofin.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Auranofin · interactions on record
113 records
- 16 severe
- 69 moderate
- 28 info
Most severe, free to view
- CladribineL01BB04severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- CladribineL04AA40severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Auranofin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be4d8a3b-2fb7-4b42-ac8c-7c07375a5702 GET /v1/drugs/be4d8a3b-2fb7-4b42-ac8c-7c07375a5702?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Auranofin",
"merkevare_id": "ID_2BB34A69-399D-4F7F-AFEE-A82AA911C414",
"name_form_strength": "Ridaura kaps 3 mg",
"prescription_group": "C"
}See everything about auranofin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.